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Abstract.  The lymphocyte-specific phosphoprotein 
LSP1 associates with the cytoplasmic face of the 
plasma membrane and with the cytoskeleton. Mouse 
LSP1 protein contains  330 amino acids and contains 
an NH2-terminal acidic domain of •177  amino acids. 
The COOH-terminal half of the LSP1  protein is rich 
in basic residues.  In this paper we show that LSP1 
protein which is immunoprecipitated with anti-LSP1 
antibodies from NP-40-soluble lysates of the mouse 
B-lymphoma cell line BALl7 is associated with actin. 
In vitro binding experiments using  recombinant LSPI 
(rLSP1) protein and rabbit skeletal muscle actin show 
that LSP1  binds along the sides of F-actin but does 
not bind to G-actin.  rLSP1  does not alter the initial 
polymerization kinetics of actin.  The highly conserved 
COOH-terminal basic domains  of mouse and human 
LSP1  share a  significant homology with the 20-kD 
COOH-terminal  F-actin binding  fragment of caldes- 
mon.  A  truncated rLSP1 protein containing  the entire 
COOH-terminal basic domain from residue  179 to 
330, but not the NH2-terminal  acidic domain binds to 
F-actin at least as well as rLSP1.  When LSP1/CAT 
fusion proteins are expressed in a LSPl-negative 
T-lymphoma cell line,  only fusion proteins containing 
the basic COOH-terminal domain associate with the 
NP-40-insoluble cytoskeleton. These data show that 
LSP1 binds F-actin through its COOH-terminal basic 
domain and  strongly suggest that LSP1 interacts with 
the cytoskeleton by direct binding  to F-actin.  We pro- 
pose that LSP1 plays a  role in mediating cytoskeleton 
driven responses in lymphocytes such as receptor cap- 
ping,  cell motility, or cell-cell interactions. 
E  is a  lymphocyte-specific intracellular  Ca2§ 
phosphoprotein  (18-20).  LSP1  protein  contains an 
acidic  NH~-terminal  and  a  basic  COOH-terminal 
domain,  the  latter  being  highly  conserved  between  the 
mouse and the human predicted amino acid sequences (19). 
In the mouse B-lymphoma cell line  BALl7,  LSP1  is dis- 
tributed in three different subcellular fractions.  ,x, 25 % of to- 
tal  cellular  LSP1 associates with  the cytoplasmic face of 
the plasma membrane,  t0-20% with the cytoskeleton, and 
the rest partitions  to soluble cytoplasm (20, 21). Activation 
of B-lymphoma cell lines by cross-linking  of  their membrane 
immunoglobulin  (mIg) t  molecules with anti-Ig  antibodies 
results in the aggregation of  LSP1 directly under the extracel- 
lular  caps formed by cross-linked mIgM  molecules (21). 
This localization  of LSP1 beneath  caps, and its association 
with both lymphocyte membrane and cytoskeleton, impli- 
cates LSP1 in the cytoskeletal remodeling after B-cell acti- 
vation. 
Normal resting  B-lymphocytes which express mIg mole- 
cules on the surface as antigen receptors undergo a transition 
from the Go to G~  stage after treatment  with anti-Ig  anti- 
1. Abbreviations  used in this paper: CAT, chloramphenicot acetyl transfer- 
ase; mlg,  membrane  intrmmoglobulin; OGP,  1-O-n-octyl-b-D-glucopyra- 
nosid; rLSP1, recombinant LSP1. 
bodies (10, 40). Some of the biochemical changes in the cell 
after activation of resting B-cells or B-lymphoma lines with 
antigen  or anti-Ig  include a rapid activation  of phosphoty- 
rosine kinase activity (8,  12, 32), and an activation  of the 
phosphatidylinositol  pathway (3, 9, 31). Moreover, the intra- 
cellular free Ca  2§ increases rapidly and transiently  within 
seconds after  anti-Ig  stimulation  (36,  37).  In  addition  to 
these biochemical changes,  dramatic  structural  changes oc- 
cur in activated B-cells as well.  These include  the rapid as- 
sociation of a fraction of mIg molecules with the cytoskele- 
ton (1, 5, 45), a rapid increase in polymerized F-actin (29), 
patching, capping, and endocytosis of  mlg molecules (4) and 
a rapid and transient  stimulation  of cell motility (39). Even- 
tually all or part of these biochemical and structural  changes 
cooperate with  signals  delivered by lymphokines such as 
IL-4 to initiate new DNA synthesis and cell growth (17) and 
it has become apparent  that the cytoskeleton plays a central 
role in the transmission  of these mitogenic signals  (1,  14, 
29, 38). 
To determine how LSP1 protein might be involved in the 
regulation  of cytoskeletal structure we investigated if LSP1 
interacts with other cellular proteins.  Using immunoprecipi- 
tations,  direct binding  studies and EM, we show that LSP1 
is an F-actin binding protein which binds to the sides of actin 
filaments. The COOH-terminal basic domain of LSP1 binds 
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cytoskeleton in intact cells. This suggests that the cytoskele- 
tal localization of LSP1  is due to its binding to F-actin. 
Materials and Methods 
Cells and Antisera 
The mouse mlgM  +, and mlgD  + B-lymphoma line BALl% mlgM  + B-lym- 
phoma line WEHI231, and T-lymphoma line BW5147 were grown in com- 
plete RPMI-1640 tissue culture medium supplemented with 10%  FCS as 
described (20). 1"22 is a clonal derivative of the LSP1 + BW5147 transfec- 
tant no. 2 (20). The anti-LSP1 serum was made in rabbits against the mouse 
recombinant LSP1 protein (rLSP1) (20). LSPl-specific affinity purified anti- 
bodies were isolated by passing this serum through a column of rLSP1 cou- 
pled to CNBr-activated Sepharose. The monoclonal anti-actin antibody 
14.3  was supplied as a  hybridoma supernatant and was a  gift from Dr. 
Dominique Aunis (Centre de Neurochimie, Strasbourg, France). Polyclonal 
rabbit anti-chloramphenicol acetyl transferase (CAT) antiserum was pur- 
chased from 5'-3', Inc. (Boulder, CO). 
Immunoprecipitations 
BALl7 cells (106 cells/ml) were washed once with prewarmed HBSS and 
were labeled for 16 h in 90%  methionine-free and  10% complete culture 
medium (1% final FCS) containing 10 #Ci/ml [35S]methionine  (Translabel, 
1,000 Ci/mmol; ICN K&K Laboratories Inc., Plainview, NY). After label- 
ing, the cells were washed twice with HBSS and lysed at a concentration 
of 107 cells/ml in a lysis buffer containing 50 mM Tris-HCl, pH 7.2,  150 
mM NaCI,  1 mM MgCI2, 0.5% NP-40, 14 #g/ml aprotinin, 1 mM PMSE 
2 #g/ml leupeptin,  1 #g/ml pepstatin A, and either 2 mM EGTA or 100 
#M  CaC12, as  indicated.  Immunoprecipitations were performed as de- 
scribed previously (30)  using afffinity-purified anti-LSP1 antibodies, total 
anti-LSP1  serum,  or  normal  rabbit serum.  Protein A-Sepharose beads 
(Sigma Chemical Co., St. Louis, MO) were prepared in lysis buffer as 1:1 
slurry and 15 #1 of this slurry was added to lysates corresponding to 3  ￿ 
106 cells.  The  beads  were washed three times with RIPA  (radioimmu- 
noprecipitation assay) buffer (50 mM Tris-HCl, pH 7.2,  150 mM NaC1, 
1 mM MgC12, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, and either 2 mM 
EGTA or  100  #M Ca  2+) and once with TBS, pH 7.2,  containing either 
2  mM  EGTA  or  100  #M  Ca  2+.  The immunecomplexes were collected 
from the beads by addition of 50 #1 Laemmli sample buffer (25) and immer- 
sion in boiling water for 5 min followed by centrifugation in a microfuge 
for 5 rain. The immunecomplexes from 3  x  106 cells were analyzed on a 
SDS-10% acrylamide gel by fluorography. 
Western Blot Analyses 
Protein  samples were  separated on  SDS-10%  polyacrylamide gels and 
Western blot analysis was performed on Immobilon membranes (Millipore 
Corp., Bedford, MA) using the Bio-Rad Immunblot Assay Kit (Bio-Rad 
Laboratories, Richmond, CA) as described (20). 
Rabbit Skeletal Muscle G-actin 
Rabbit skeletal muscle F-actin (42) was dialyzed extensively against G-buf- 
fer (2 mM Tris-HC1,  pH 7.6, 0.2 mM ATE 0.2 mM DTT,  and 0.2 mM 
CaCI2).  G-actin  thus  obtained  was  centrifuged  in  a  Beckman  airfuge 
(Beckman Instruments, Inc., Fullerton, CA) (28 psi, 1 h) to eliminate the 
remaining filaments and was stored on ice for use within 1 wk. 
Preparation of  DNAasel-Sepharose Beads 
DNAaseI from bovine pancreas (grade I,  Boehringer Mannheim Corp., 
Montreal, Quebec) was coupled to CNBr-activated Sepharose beads (Sigma 
Chemical Co.) according to the Pharmacia Fine Chemicals (Piscataway, 
NJ) manual. The coupling was performed by incubation overnight at 4~ 
Beads were stored at 4~  in 50 mM Tris-HCl, pH 7.2, 0.5 mM CaCI2, and 
0.01% methiolate as 1:1  slurry. 
Preparation of  NP-40 Soluble Lysates  for Binding to 
the DNAasel-Sepharose Beads 
Cell lysates were prepared as described above using a slightly modified lysis 
buffer which contained 20 mM Tris-HCl, pH 7.2,  100 mM NaC1,  0.4% 
NP-40,  and 2 mM EGTA with protease inhibitors as indicated above. ATP 
and DTT  were added to the lysates to final concentrations of 0.2  mM. 
DNAaseI-Sepharose beads (200 #1 1:1 slurry) were equilibrated by washing 
five times with the above buffer containing 0.2 mM ATP and 0.2 mM DTT 
before incubating with 1 ml lysate (107 cells) for 15 min at room tempera- 
ture with end-over-end mixing. The beads were then spun at 13,000  rpm 
for 2  rain and the supernatants were collected. To analyze the material 
bound to the DNAase I beads, beads were washed five times with the above 
buffer containing ATP and DTT  and boiled in 250 #1  Laemmli sample 
buffer. 
F-actin Binding Assay and Scatchard Plot Analyses 
Proteins in P-buffer (10 mM imidazole, pH 7.0, 75 mM KC1, 0.2 mM DTT, 
0.2 mM EGTA, 0.01% NP-40) were prespun in an airfuge (28 psi, 1 h) and 
mixed with G-actin. Control samples were mixed with an equivalent amount 
of G-buffer. Assays were performed in P-buffer containing 2 mM MgC12 
and 0.1 mM ATP in a final volume of I00 #1. After incubation for 45 rain 
at room temperature the samples were spun in an Airfuge (28 psi,  1 h). 
Laemmli sample buffer was added to both supernatants and pellets which 
were analyzed by SDS-PAGE and Coomassie staining. For Scatchard plot 
analyses, stained gels were scanned with a Hewlett Packard ScanJetPlus in- 
strument (Mountain View, CA) and the density of each LSP1 and actin band 
was measured using the integrated density function of Image software ver- 
sion 1.29 (National Institutes of Health, Bethesda, MD). Each gel contain- 
ing either pellets or supernatants from sedimentation assays also contained 
a series of lanes with known amounts of both actin and LSP1 spanning the 
range of amounts expected for the samples to be measured. For each gel, 
a calibration curve was constructed by plotting the density of the actin and 
LSP1 bands versus amounts of actin or LSP1 determined by optical density 
measurements at 290 and 280 nm, respectively, using extinction coefficient 
of 25800 mol-lcm  -l for actin and 34560 mol-lcm  -t for LSP1. The amount 
of protein in unknown samples was then calculated from a linear fit to the 
calibration curve. The amount of LSP1 bound to actin was taken from the 
ratio of LSP1 to actin in each pellet and is expressed in molar terms relative 
to sedimented actin. The amount of LSP1  remaining in the supernatant is 
taken as representing free LSP1. 
Fluorescence and Light-Scattering Measurements 
Fluorescence and light scattering at 90~  during the polymerization of 
pyrene-labcled actin were measured simultaneously in a Porkin-Elmer LS- 
50 instrument (The Pork.in-Elmer Corp., Norwalk, CT) using the Intracel- 
lular Biochemistry setting which allows rapidly alternating measurements 
of light emitted at two wavelengths. The exciting wavelength was set at 365 
rim, within the excitation peak of the pyrene label, and the emission wave- 
length alternated between 386 run to measure fluorescence and 365 run for 
scattering. The slit widths were set to 2.5 nm for both emission and excita- 
tion, and the period between two successive fluorescence or scattering mea- 
surements was 1.1 s. 3 #M pyrene-labeled G-actin was added to 300 #1 PO 
buffer or to PO buffer containing either 3.5 #M LSP1 or 0.06 #M geisolin 
and 200 #M CaCI2.  PO buffer is similar to P buffer except it contains 7.5 
mM 1-0-n-octyl-b-D-glucopyranosid  (OGP) (Beehringar Mannheim Corp.) 
instead of 0.01% NP-40.  Polymerization was initiated by adding 0.2 mM 
ATP and 2.0 mM MgC12 immediately after addition of G-actin. 
Electron Microscopy 
Negative staining of actin filaments with or without rLSPl or the 5-1 fusion 
protein was performed using 2% uranyl acetate. Purified rLSP1 and 5-1 pro- 
teins were visualized by rotary shadowing with tantalum-tungsten at 5 ~  . 
Proteins in 50% glycerol were sprayed onto mica, dried in a vacuum, and 
metal coated (43). 
Expression of  LSP1/CAT Fusion Proteins 
and Truncated Fusion Proteins 
The eDNA insert of pJJ32 (18) was excised with EcoRI and transferred to 
the EcoRI site of the Bluescript plasmid vector such that the 5' end of the 
cDNA was close to the PstI site in the Bluescript polylinker. After digestion 
with ClaI and religation, the Bluescript vector contained the LSP1 transla- 
tion initiation codon followed by five NH2-terminal LSF1 amino acid res- 
idues (pBS/LSP1-ATG).  The pBS/LSP1-ATG plasmid was cut with SalI and 
XhoI and a CAT cassette with SalI linkers at both ends encoding the chlor- 
amphenicol transferase enzyme, CAT (Pharmacia Fine Chemicals) was in- 
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orientation to give pBS/LSP1-ATG/CAT.  In a final step the ApaI site in the 
polylinker of this plasmid was converted to a BamHI site using a BamHI 
linker. This allowed us to excise the LSP1/CAT sequences as a BamHI frag- 
ment. The 711 expression vector was then constructed by transferring the 
BamHl fragment of pBS/LSPI-ATG/CAT to the unique BamHI site of the 
eukaryotic expression vector pBJl-neo (27), which had been modified as fol- 
lows. The unique XhoI site in pBJl-neo was converted to a BamHI site by 
insertion of a linker sequence, the resulting plasmid was cut with BamHI 
and religated resulting in the deletion of all polylinker sequences. After en- 
suring that the translation initiation codons of LSPI and CAT were in the 
same reading frame by sequencing we transfected the 711 vector into the 
T-lymphoma line BW5147 and selected a stably transfected G418 (Geneti- 
cin, Gibco Laboratories, Grand Island, NY) resistant cell line, BW711 (see 
Fig.  8).  The  fusion protein expressed in  BW711  consists of six  NH2- 
terminal LSP1  amino acids followed by 16 residues encoded by the pBS 
polylinker and the CAT 5' untranslated region followed by the 219-amino 
acid residue CAT protein. Other LSP1/CAT  fusion proteins (see Fig. 8 for 
a  schematic representation) were expressed after cloning the appropriate 
fragments of LSP1  eDNA in ClaI/SalI cut 711 vector and all contain the 
six NH2-terminal LSP1 amino acids and 14 residues encoded by the pBS 
polylinker and the CAT 5' untranslated region. LSP1  fragments were iso- 
lated by PCR amplification using pJJ32 as a template with forward primers 
containing a ClaI recognition site and reverse primers containing a SalI rec- 
ognition site at their 5' end. 
To express 5-1a and 6-1a recombinant proteins the BamHI fragment con- 
taining the LSP1/CAT fusion construct used to establish cell lines BW57 (for 
5-1a) and BW71 (for 6-1a) were transferred to pBS and a frame shift mutation 
was introduced at the SalI site resulting in the translation of 12 amino acids 
of the vector sequences between LSP1  and CAT after which the reading 
frame is interrupted by a translational stop codon. Thus 5-1a protein con- 
tains the complete acidic domain of LSP1  (residues 1-178) followed by 12 
vector derived residues,  while 6-1a protein contains the  first six  NH2- 
terminal  LSP1  residues  followed by  the  complete LSP1  basic  domain 
(residues 179-330) and the 12 vector derived amino acids. After transfer 
of the BamHl fragments to the prokaryotic expression vector pET-3c the 
5-1a and 6-1a proteins were expressed and purified as described below.  To 
prepare 5-1  recombinant protein the A-CAT  insert (see Fig. 8)  was sub- 
cloned into the pET-3c vector and the protein was purified as described be- 
low. All recombinant proteins expressed from the pET-3c vector contain 11 
identical vector derived amino acid residues at their NH2 terminus (20). 
Purification of  Recombinant Proteins 
The purification was performed essentially as described (20) except that af- 
ter removal of SDS the samples were further dialyzed against P buffer con- 
taining 0.01% NP-40.  Protein samples were concentrated using a Centri- 
prep-10 concentrator (Amicon, Beverly, MA). 
Determination of  LSP1 and LSP1/CAT Fusion 
Proteins in the Cytoskeletal Fractions 
Cytoskeletal fractions were obtained as described (21, 34) by lysis of cells 
in an NP-40-containing buffer and low-speed centrifugation for 10 min at 
600 g. The amount of wild-type LSP1 or LSP1/CAT  fusion proteins in the 
cytoskeletal fractions was determined by Western blotting as a percentage 
of that present in a total cell lysate prepared by lysing cells in SDS contain- 
ing Laemmli buffer. This was done as described (21) by comparing the LSP1 
signal in a series of twofold dilutions of the NP-40 insoluble pellets to the 
signal in a constant amount of total cell lysate. The ratio of cell equivalents 
of NP-40-insoluble pellet and total cell lysate needed to obtain equal signals 
was used to calculate the percentage of LSP1 protein in the NP-40-insoluble 
pellet. 
Results 
Previously we have commented on the lack of significant se- 
quence  homology between  the  predicted  amino  acid  se- 
quence of LSP1 and sequences in the GenBank and NBRF 
databases (18, 19).  However, as shown in Fig.  1, a search of 
updated databases revealed a 46% homology (34% identical 
amino acids and  12%  chemically conserved substitutions) 
between the 20-kD COOH-terminal actin binding fragment 
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Figure 1. Comparison of the predicted protein sequences of the ba- 
sic domains of the mouse and human LSP1  proteins with the se- 
quence of the COOH-terminal F-actin binding fragment of caldes- 
mon. The abbreviations mo, hu, and cal on the right indicate mouse 
LSP1, human LSP1, and chicken caldesmon, respectively. Gaps are 
introduced for optimal alignment. (-) Residues identical with those 
directly above. Boxes indicate identical amino acids in either one 
or both of  the LSP1 proteins and caldesmon. Chemically conserved 
substitutions are circled. Numbers on the left correspond to amino 
acid  positions  starting  at  the  NH2  terminus  of the  protein  se- 
quences. These sequence data are available from GenBank under 
accession number M33552 (huLSP1) and from NBRF under acces- 
sion numbers  A30533  (moLSP1)  and A32642  (cal). 
of chicken smooth muscle caldesmon (6) and the highly con- 
served COOH-terminal basic domains of mouse and human 
LSP1  protein  (19).  This  sequence  spans  152  amino  acid 
residues  and  includes  homology to  regions  of caldesmon 
which  are  required  for  binding  to  F-actin  (44).  This  se- 
quence homology, and the finding that up to 20 % of LSP1 
is cytoskeletal in lymphocytes prompted us to determine if 
LSP1 binds actin, and since LSP1 binds Ca  2§ (20) we asked 
whether such an interaction would be  modulated by Ca  2§ 
LSPI Interacts with Actin in BAL17 Lysates 
To determine whether the intracellular protein LSP1  is as- 
sociated with actin we immunoprecipitated the LSP1 protein 
from the mouse sIgM +, sIgD + B-lymphoma cell line BALl7 
in the presence of Ca  2+ or EGTA.  Fig. 2 a illustrates a typi- 
cal result of such an immunoprecipitation. In addition to the 
52-kD band which was identified as a product of the LSP1 
gene  (indicated  by  an  open  arrowhead  in  Fig.  2)  (20),  a 
prominent 42-kD protein (p42, indicated by a closed arrow- 
head in Fig.  2) was present in the presence of either 2 mM 
EGTA (Fig. 2 a, lane 1 ) or 100/~M Ca  2+ (Fig. 2 a, lane 2). 
Fig.  2  a  also  shows that immunoprecipitates formed with 
normal rabbit serum did not contain the LSP1  or p42 pro- 
teins either in the absence (Fig. 2 a, lane 3) or presence (Fig. 
2 a, lane 4) of Ca  2+. The nature of the 90-kD band present 
in Fig.  2  a,  lanes 1 and 2  is as yet unknown. 
To  determine  whether  the  presence  of p42  in  our  im- 
munoprecipitates is due to a cross-reaction of the anti-LSP1 
serum  with  p42,  immunoprecipitations  were  performed 
from the transformed T-cell line BW5147 which does not ex- 
Jongstra-Bilen  et al. LSP1 Binds to F-actin  1445 shown).  These data confirm that  actin is the  p~S]methio- 
nine-labeled p42 shown in Fig. 2 a  to interact with LSP1. 
Figure 2. LSP1 binds to actin. (a) Immunoprecipitations were per 
formed in the presence of 2 mM EGTA (lanes 1 and 3) or 100 #M 
Ca  2+ (lanes 2  and 4) with affinity purified anti-LSP1 antibodies 
(Ab, lanes I and 2) or with pre-immune normal rabbit serum (NRS, 
lanes 3 and 4) at 1:500 and 1:200 dilutions, respectively. The open 
arrowhead indicates the position of the 52-kD LSP1 protein while 
the closed arrowhead indicates the position of purified rabbit skele- 
tal muscle actin used as a marker protein. The numbers to the left 
correspond to the positions of  marker proteins with their molecular 
mass indicated in kilodaltons.  (b) Immunoprecipitates of LSP1- 
T-cell line BW5147 (lanes 1 and 2) and its LSP1  + derivative T22 
(lanes 3 and 4) after lysis in the presence of either 2 mM EGTA 
(lanes 1 and 3) or 100 #M Ca  :+ (lanes 2 and 4). The positions of 
LSP1 and of the actin marker are indicated with an open and closed 
arrowhead at the left.  (c) Immunoprecipitations performed with 
anti-LSP1 serum (S, lane 1) or normal rabbit serum (NRS, lane 2) 
at 1:200 dilutions were analyzed by Western blotting using mAb 
against rabbit skeletal muscle actin at a dilution of 1:10. The posi- 
tion of purified rabbit skeletal muscle actin is indicated with an ar- 
row to the left. 
press LSP1 protein and from its LSP1  + derivative T22, es- 
tablished by transfection with LSP1 cDNA in the expression 
vector pECE-B (20).  Fig. 2 b  shows that no 1342 or LSP1 
were present in immunoprecipitates from BW5147 cell ly- 
sates made in 2 mM EGTA or 100 ttM Ca  :+ (Fig. 2 b, lanes 
1 and 2), while both p42 and LSP1 were precipitated from 
such lysates of the LSP1  + T22 transfectant (Fig.  2 b, lanes 
3 and 4). These results show that p42 is present in BW5147 
cell lysates but is only precipitated with anti-LSP1 antibodies 
when LSP1  protein is present as well. We conclude from 
these data that 1942 and LSP1 form a protein complex in the 
cell lysate in a  Ca:+-independent manner. 
Based on its molecular weight and on its comigration with 
purified actin in NEPHGE/SDS-10 % acrylamide two-dimen- 
sional gels  (not shown)  we predicted p42  to be actin.  To 
verify this point we analyzed [35S]methionine-labeled anti- 
LSP1 immunoprecipitates by Western blotting using mAbs 
against rabbit skeletal muscle actin (Fig.  2  c).  This mAb 
identified p42 as actin only in the anti-LSP1 immunoprecipi- 
tate (Fig. 2 c, lane 1) but not in the precipitate formed with 
pre-immune rabbit serum (Fig. 2 c, lane 2), identical to the 
pattern obtained by autoradiography of the Western blot (not 
LSP1 Binds to F-actin but not to G-actin 
Control experiments established that rLSP1 is not soluble 
under conditions of actin polymerization unless some NP-40 
detergent was added.  We therefore routinely added 0.01% 
NP-40 to all our F-actin binding assays.  Fig. 3 a, lanes 1-3 
show that rLSP1 is soluble in the presence of 0.01% NP-40 
when incubated in the absence of actin. However, upon addi- 
tion of G-actin and after polymerization, a significant por- 
tion of added rLSP1 cosediments with F-actin (Fig. 3 a, lane 
5) while a small fraction remains in the supernatant (Fig. 3 
a,  lane  4).  LSP1  does  not  affect the  amount  of F-actin 
sedimenting in this assay system (compare Fig. 3 a, lanes 4 
and 5 with lanes 6 and 7). The binding of rLSP1 to F-actin 
was not affected by the addition of 0.1  mM Ca  2+ or 0.2 M 
NaC1 to the assay media (data not shown). The same results 
were obtained when LSP1 from actin depleted NP-40 soluble 
BALl7 lysates was used as a source of native LSP1 to bind 
to  F-actin  in  vitro  (not  shown).  Fig.  3  b  illustrates  a 
specificity control with BSA. Whether incubated under poly- 
merization conditions in the absence (Fig. 3 b, lanes I  and 
2) or presence (Fig. 3 b, lanes 3 and 4) of actin all of the BSA 
remains in the supernatant fractions as soluble protein. We 
conclude from these in vitro actin-binding assays that LSP1 
protein binds to F-actin in a Ca:+-independent manner. 
To check whether the basic domain of LSP1, which con- 
tains the homology with the F-actin binding domain of cal- 
desmon (see Fig.  1), binds to F-actin we performed similar 
experiments with the truncated LSP1 recombinant protein, 
6-1a, which contains the entire basic domain of LSP1. Fig. 
3 c shows that while the 6-1a protein is soluble in the absence 
of actin  (Fig.  3  c,  lanes  1  and  2),  most of this  protein 
coprecipitates with F-actin (Fig.  3 c, lanes 3  and 4).  The 
same assay was also performed with another truncated LSP1 
protein, 5-1a, which contains the entire acidic NH2-terminal 
domain of LSP1 and the same additional amino acids from 
the vector as for 6-1a (see Materials and Methods). This pro- 
tein did not bind to F-actin (not shown) indicating that the 
additional residues from the vector do not bind directly to 
F-actin. We thus conclude that it is the basic COOH-terminal 
domain of LSPI,  containing a  significant homology with 
the F-actin binding domain of caldesmon, which binds to 
F-actin. 
A quantitative analysis of cosedimentation of rLSP1 with 
purified F-actin confirms the specificity and high affinity of 
the LSP1/actin interaction. Fig. 4 a  shows that the amount 
ofrLSP1 which sediments with F-actin approaches a limiting 
value near a  molar ratio of 1:1 at a  10-fold excess of total 
LSP1 to sedimented actin. Scatchard analysis of similar data 
taken from five separate experiments (Fig. 4 b) suggests that 
there is a specific binding interaction with a dissociation con- 
stant  of ~,0.2  /zM  and  an  apparent  stoichiometry of 0.6 
recombinant LSP1 (rLSP1) molecules for each actin subunit. 
This binding affinity is comparable with that of caldesmon 
for actin (0.15-0.3 #M) (47). There appears to be a second 
type of low affinity (apparent Ks >  5  #M) interaction that 
does not approach saturation at the concentrations of rLSP1 
that  can  be  achieved experimentally,  consistent  with  the 
slight increase in binding seen in Fig.  4  a.  It is  not clear 
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F-actin binding assay of rLSP1, BSA 
and 6-1a analyzed by SDS-PAGE and 
staining  with  Coomassie  blue.  (a) 
rLSP1,  50  /~g/ml  (lanes  1-3)  or 
G-aetin, 250 tzg/ml (lanes 6 and 7) or 
both (lanes 4 and 5) were used for the 
assay. Half of the pellets (P) and the 
supematants (S) were analyzed except 
in lanes 2 and 3 which contain  12.5 
and 37% of the supernatant,  respec- 
tively. (b) BSA, 50 t~g/ml (lanes I and 
2) or a mixture of the same amount of 
BSA and G-actin, 250 tzg/ml (lanes 3 
and 4) were treated and analyzed as 
above. (c) The 6-1a protein (45 ~g/ml) 
(lanes 1 and 2) or the same amount of 
6-1a with G-actin, 160 t~g/ml (lanes 3 
and 4) were used in the assay and one 
third of the pellets (P) and the super- 
natants (S) were analyzed on the gel. 
whether the low-affinity binding represents a second F-actin 
binding site in LSP1 or represents some nonspecific binding 
or trapping of LSP1 within the actin network during sedi- 
mentation..Experiments to map the F-actin binding sites in 
LSP1 are presently ongoing and should help to resolve this 
question. The stoichiometry of 0.6 indicated by the Scatch- 
ard analysis may be an overestimation since ultrastructural 
analyses of LSP1/F-actin complexes by EM (see below) re- 
vealed the existence of large particles possibly containing 
several rLSP1  molecules along the sides of the actin illa- 
ments. Thus we can not exclude the possibility that this high 
stoichiometry is due to the presence of nonactin-bound LSP1 
molecules associated with actin-bound LSP1. 
LSP1 did not greatly affect the rate of actin polymeriza- 
tion. When actin polymerized in solutions containing more 
than equimolar amounts of LSP1, the initial rate of polymer- 
ization, as measured by changes in pyrene fluorescence was 
the same as that of actin lacking LSP1 (Fig. 5 a). At later 
times,  when ~20%  of the actin polymerized, the fluores- 
cence increase was slightly retarded by LSP1, but there was 
no significant effect of a range of LSP1 concentrations on the 
final fluorescence levels of pyrene-labeled F-actin (data not 
shown). These results show that LSP1 does not nucleate the 
formation of actin filaments, which would lead to a large in- 
crease in initial rate of polymerization under these condi- 
tions, as confirmed by the effect of gelsolin shown in Fig. 5 
a.  LSP1  also  does  not  bind  to  G-actin  with  an  affinity 
sufficient  to  prevent  nucleation  or  the  incorporation  of 
monomers into filaments. 
In contrast to the lack of  effect  on the rate of  actin polymer- 
ization,  Fig.  5  b  shows  that  rLSP1  augments  the  light- 
scattering intensity of  F-actin during polymerization. The in- 
creased scattering cannot be attributed to additive effects of 
actin and LSP1 since the latter shows no change in scattering 
after addition of Mg  2+ and ATP necessary for actin poly- 
merization.  Similar  results  with  fluorescence  and  light- 
scattering measurements were obtained when experiments 
were performed in the presence of NP-40 instead of OGP as 
detergent. These results, together with the lack of effect on 
initial fluorescence changes suggest that LSP1 binds actin af- 
ter its polymerization and forms larger aggregates, possibly 
by promoting the lateral association of the filaments. 
Electron micrographs of F-actin incubated with rLSP1 are 
strikingly different from actin alone (Fig. 6 a). Filaments are 
bundled and decorated along their sides by small particles 
of 10-40 nm in diameter (Fig. 6, b and c). As shown in Fig. 
6 d, purified specimens of rLSP1 in NP-40 appear as 10-20- 
nm particles after metal shadowing. These particles were no 
longer visible by metal shadowing when rLSP1 was preab- 
sorbed onto protein A-Sepharose beads coated with affinity- 
purified anti-LSP1  antibodies  (not  shown)  indicating that 
rLSP1 is present in these particles. It is likely therefore that 
the particles which are intimately associated with actin illa- 
ments are the same as those observed in purified rLSP1 sam- 
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Figure 4.  Binding of rLSP1 to F-actin. (a) The amount of rLSP1 
cosedimenting with F-actin is shown for one series of experiments 
in which 2 #M G-actin was mixed with various concentrations of 
LSP1 and then polymerized in 2 mM MgC12 and 75 mM KC1 as 
described in Materials and Methods. Under these conditions, 0.8 
#M F-actin was recovered in the pellet independent of the amount 
of rLSP1 present. (b) Scatchard analysis of several binding experi- 
ments using either 2 or 5.9/~M actin.  Constant values of 0.8  x 
10  -1~ or 4 x  10  -I~ moles respectively were used for the sedimented 
actin. Bound and free LSP1 are expressed as the molar concentra- 
tions of LSP1 recovered in the pellet and supernatant, respectively. 
The line  from  which an apparent  binding affinity is  estimated 
represents a linear least square fit to the binding data for bound 
LSP1/actin values <0.5. 
pies. The size of the particles are such that they may contain 
several LSP1 molecules and the fact that these panicles are 
soluble even after prolonged ultracentrifugation leads us to 
speculate  that  the  detergent  which  is  necessary  to  keep 
rLSP1 soluble may be part of these particles as well. The lo- 
calization of these panicles on actin filaments appears to be 
dependent on the actin-binding COOH-terminal domain of 
rLSP1. When F-actin is incubated with rLSP1 the presence 
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Figure  5.  Fluorescence  and  light  scattering  measurements.  (a) 
Pyrene-labeled actin was polymerized in the presence or absence 
of LSP1 or gelsolin as described in Materials and Methods. The 
fluorescence (a) and light scattering intensity (b) is shown during 
the initial stage of  polymerization in which the pyrene fluorescence 
of control samples containing only actin reached •30  % of their 
final fluorescence levels. 
of these panicles is markedly reduced in regions lacking ac- 
tin filaments (Fig. 6, b and c). However, when the truncated 
LSP1/CAT  recombinant  fusion  protein,  5-1, lacking  the 
COOH-terminal domain and F-actin binding capacity (not 
shown) is used particles, which also appear in the purified 
protein specimens (Fig. 6 f), are scattered across the grid 
(Fig. 6 e). Furthermore, the 5-1 protein did not aggregate the 
F-actin filaments. We conclude that the bundling of F-actin 
filaments  by  rLSP1  requires  the  COOH-terminal  F-actin 
binding site of  the molecule, since the 5-1 fusion protein does 
not bind to F-actin nor alters the morphology of  the actin fila- 
ments (Fig. 6 e) as compared with actin alone (Fig.  6 a). 
These observations together with the light scattering experi- 
Figure 6.  The effects rLSP1 and 5-1 on the ultrastructure of F-actin (a-c, and e) and the structure of rLSP1 (d) and 5-1 (f). 3 #M actin 
was incubated in P buffer without LSP1 (a) or with 3 #M LSP1 (b), 1.5 #M LSP1 (c), or with 3 #M 5-1 (e). Actin filaments were visualized 
by negative staining. (d and f) 1.5 #M rLSP1 (d) and 1.5 #M 5-1 (f) were visualized by metal coating. The magnification of  all micrographs 
is identical. Bar, 0.2 #m. 
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of BALl7 lysates before and after incubation with DNAaseI-Seph- 
arose beads.  Material bound to the beads (B) and the unbound 
material in the supernatant (S) were analyzed together with differ- 
ent aliquots of the total lysate (INPUT) using anti-LSP1 serum 
(1:2,000) and anti-actin antibodies (1:10) simultaneously. The size 
of the aliquots is indicated in cell equivalents across the top of the 
figure. Lane  7 represents 200 ng purified rabbit skeletal muscle 
actin.  (b) DNAaseI-Sepharose  beads (50 #1  1:1 slurry) were in- 
cubated with 20 t~g rabbit skeletal muscle G-actin without (lanes 
1, 2, and 5) or with 60 t~g rLSP1 (lanes 3, 4, and 6) and the beads 
were spun. Aliquots of  the bound (8) and the unbound material (S) 
were  analyzed  together  with  an  aliquot  of the  input  (In) on 
SDS-10%  polyacrylamide gels stained with Coomassie brilliant 
blue. Lanes 1 and 3, and 2 and 4 represent 1/20th of the input and 
supernatant, respectively. Lanes 5 and 6 represent one fourth of the 
bound material. 
ments and the stoichiometry of binding lead to the conclu- 
sion that binding to F-actin occurs along the sides of the actin 
filaments. 
To determine whether LSP1 binds to G-actin we prepared 
an NP-40-soluble BALl7 lysate containing the LSP1/actin 
complex and incubated this lysate with DNAaseI-Sepharose 
beads. DNAaseI binds with high affinity to G-actin (26, 28) 
so that if the actin in the LSP1/actin complex in the lysate 
is G-actin one might expect this complex to be retained on 
the beads. Fig. 7 a shows the result of a typical experiment. 
The anti-LSP1 serum specifically recognizes  a doublet of  pro- 
teins of a 52-kD LSP1 band and a 50.5-kD as yet uncharac- 
terized band (20). On the blots, the amount of LSP1 and actin 
present in the different samples was estimated by comparing 
the LSP1 or actin signal in a sample to the signal present in 
increasing amounts (expressed as cell equivalents) of the un- 
fractionated lysate used as input (Fig. 7 a, lanes 1-4). Com- 
parison of the actin signals in Fig. 7 a, lanes 4 and 5 show 
that  >95 %  of the actin  is  removed from the lysate after 
pelleting the DNAaseI-Sepharose beads.  However, essen- 
tially all of the LSP1 remains in the lysate. This is also iUus- 
trated in Fig. 7 a, lane 6 which shows that actin is bound to 
the beads  while no bound LSP1  could be detected,  even 
when five times more beads than shown in Fig. 7 a, lane 6 
were  analyzed  (not  shown).  These  results  indicate  that 
>95 % of the actin present in a NP-40-soluble BALl7 cell ly- 
sate is not bound to LSP1. 
An alternative explanation of the above results could be 
that occupation of  the LSPl-binding site on G-actin interferes 
with  the  binding  of G-actin  to  DNAaseI  so that  G-actin 
bound to LSP1 can no longer bind to DNAaseI. To determine 
whether LSP1 prevents the binding of G-actin to DNAaseI 
beads we mixed rabbit skeletal muscle G-actin with a three- 
fold excess of rLSP1  before incubating  the  mixture with 
DNAaseI-Sepharose beads. Fig. 7 b, lanes 5 and 6 demon- 
strate that the same amount of G-actin binds to the DNAaseI 
beads regardless of the presence or absence of excess rLSP1 
in the incubation mixture. This is also evident from the same 
observed drop in actin levels between the input and after in- 
cubation with the beads when actin is incubated alone (Fig. 
7 b, lanes I  and 2) or with rLSP1 (Fig. 7 b, lanes 3 and 4). 
Preincubation of  G-actin with rLSP1 for 30 min at room tem- 
perature before the incubation with the beads gave similar 
results (not shown). Fig. 7 b, lanes 3, 4, and 6 also illustrate 
that  rLSP1  does  not bind  to  G-actin bound  to  DNAaseI 
beads, which is in accord with the results shown in Fig. 7 
a  using endogenous LSP1 protein from BALl7 lysates. The 
failure of LSP1 to bind to G-actin agrees with the fact that 
LSP1 does not affect the rate of actin polymerization. 
The Basic Domain of  LSPI Contains a 
Cytoskeletal Binding Site 
Having determined that the basic  COOH-terminal half of 
rLSP1 binds directly to F-actin, we asked whether the same 
domain directs the protein to the cytoskeleton. To address 
this question we ligated different parts of the LSP1 cDNA 
coding sequence upstream of the CAT coding sequence. The 
resulting constructs were expressed as LSP1/CAT fusion pro- 
teins  in  the  LSP1- T-cell line BW5147.  Fig.  8  shows  the 
structure of wild-type LSP1 and the different LSP1/CAT pro- 
teins used. Five stably transfected cell lines were used: T22, 
expressing the wild-type LSP1; BW4,  expressing a  fusion 
protein consisting of wild-type LSPI at the NH2 terminus of 
the CAT protein (AB-CAT protein); BW57,  expressing the 
acidic LSP1 domain/CAT protein (A-CAT protein); BW71, 
expressing the basic LSP1 domain/CAT protein (B-CAT pro- 
tein); and BW711, expressing CAT protein. Fig. 9 represents 
the distribution of LSP1 and LSP1/CAT fusion proteins in 
detergent-soluble and insoluble fractions of these cell lines 
and is representative of several experiments. The percentage 
of the protein amounts in the detergent-insoluble fractions of 
these cells illustrated in Fig. 8 were obtained after more ex- 
tensive titration of the NP-40 insoluble pellets (see Materials 
and Methods).  '~10-20%  of wild-type LSP1 is associated 
with the insoluble fraction in the cell lines WEHI231 and 
T22 (Fig. 9, a and b). A similar percentage of AB-CAT pro- 
tein is also insoluble in BW4 (Fig. 9  c) indicating that the 
presence of the CAT protein COOH terminal to wild-type 
LSP1  does  not  significantly  influence the  distribution  of 
LSP1. As a further control it can be seen that only a small 
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Figure 8. Mapping of  the cytoskeletal binding domain of  LSP1. The 
top line represents the mouse LSP1 protein and indicates its divi- 
sion in a 177-amino acid long NH2-terminal acidic domain and a 
153-amino acid long COOH-terminal basic domain. The column 
labeled Protein gives the names and schematic representations of 
the wild-type and fusion proteins used in this study. The column 
labeled Cell line gives the name of  the cell line in which the protein 
is expressed and finally the amount of NP-40 insoluble wild-type 
or fusion protein is given in the last column. 
percentage (<1%) of CAT protein is insoluble in the cell line 
BW711 (Fig. 9f). Finally, the majority of  the B-CAT protein 
(50-100%, Fig. 9 d) but only a small fraction of the A-CAT 
protein (<1%,  Fig.  9  e) is present in the NP-40-insoluble 
pellets of BW71 and BW57, respectively. 
We have previously shown that LSP1 found in the deter- 
gent-insoluble fraction of the B-lymphoma cell line BALl7 
is associated with the cytoskeleton but not with nuclei which 
are also present in the detergent-insoluble fraction (21).  We 
verified whether the same is true for the truncated LSP1 fu- 
sion protein B-CAT present in the detergent-insoluble frac- 
tion of the transfectant line BW71. We prepared a crude ly- 
sate of BW71 cells in which the eytoskeletal elements were 
disrupted but in which the nuclear fraction remained intact 
using nitrogen cavitation (21) and NP-40 was added to a final 
concentration of 0.4 %, the same final concentration used to 
lyse whole cells. When this lysate was centrifuged for 10 rain 
at 600 g the yield of nuclei was essentially 100%. This was 
determined  by comparing the histone content  (as judged 
from Coomassie blue-stained gels) from equal cell equiva- 
lents of the cells before nitrogen cavitation with the NP-40- 
insoluble pellet. The amount of the B-CAT protein recovered 
in the detergent-insoluble fraction after nitrogen cavitation 
was only ,'~1-5 % of the amount found in the crude lysate in- 
dicating that the B-CAT protein found in the detergent-insol- 
uble fraction is not associated with the nuclei but rather with 
the cytoskeleton. These experiments also point out that the 
presence of high amounts of the B-CAT protein in the deter- 
gent-insoluble material is not because of the insolubility of 
this protein in the NP-40 containing lysis buffer. 
The fact that the majority of the B-CAT protein binds to 
the cytoskeleton is surprising given that the wild-type LSP1 
or the AB-CAT protein associates to a much lesser extent 
with the cytoskeleton. From these results we conclude that 
it is the actin binding COOH-terminal basic domain of LSP1 
which targets LSP1 to the cytoskeleton and that the acidic 
Figure 9. LSP1 binds to the cytoskeleton through its basic domain. 
Each panel is a Western blot analysis developed using either anti- 
LSP1 antiserum,  1:2,000 dilution (a and b) or a mixture of anti- 
LSP1 and anti-CAT  antibodies, 1:2,000 and 1:500 dilutions, respec- 
tively (c, d, and e) or anti-CAT antibodies, 1:500 dilution 0  c) and 
contains a total sample (T), a detergent-soluble fraction (S), and 
a detergent-insoluble fraction (I) from the cell lines indicated at the 
top. The size of each sample is indicated in cell equivalents at the 
bottom of each lane. 
domain may well play a role in regulating the fraction of  total 
cellular LSP1 protein which binds to the cytoskeleton. 
Discussion 
The experiments described in this paper show,  for the first 
time, that the lymphocyte-specific  protein LSP1 is an F-actin 
binding protein.  The F-actin binding  capacity of LSP1  is 
reproduced with the truncated LSP1 recombinant protein, 
6-1a, which contains the entire basic domain of LSP1 but not 
with  another truncated protein,  5-1a,  containing only the 
acidic  domain,  or  with  the  fusion protein  5-1. Although 
negative results with the latter two proteins do not exclude 
the possibility of a folding problem with these recombinant 
proteins, these results do confirm that the basic domain of 
LSP1 contains an F-actin binding site. Whether there is more 
than one actin binding site within this domain or elsewhere 
in the protein and the exact boundaries of such binding sites 
are subject for further ongoing studies. The COOH-terminal 
basic  domain of LSP1  which binds  to F-actin contains a 
significant homology with the actin binding domain of cal- 
desmon.  Also,  the same basic COOH-terminal domain of 
LSP1  binds  directly  to  the  cytoskeleton.  These  results 
strongly suggest that the LSP1-F-actin interaction also exists 
in intact lymphocytes and accounts for the binding of LSPI 
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of LSP1 is highly conserved between the mouse and human 
LSP1 proteins (19) this suggests that the F-actin binding ca- 
pacity of LSP1  is important for its function. 
The related 20-kD actin-binding fragment of caldesmon 
has been reported to bind to calmodulin and it has been pro- 
posed that the minimal calmodulin binding site consists of 
a stretch of seven amino acids from Trp-659 till Ser-666 (41, 
44).  Although mouse  LSP1  protein  shares  five identical 
residues with this calmodulin binding site, an interaction be- 
tween LSP1  and calmodulin was not detected in our im- 
munoprecipitates.  Furthermore,  preliminary  experiments 
revealed no effect of purified calmodulin on the binding of 
rLSP1  to F-actin in the presence of Ca  :+. These data are 
consistent with our finding that the interaction of LSP1 with 
F-actin is  not  sensitive to  Ca  2§  in  cell lysates.  Whether 
other factors such as phosphorylation of LSP1 influences its 
binding to F-actin remains to be determined. 
We showed that LSP1 does not bind to G-actin, which sug- 
gests that the actin bound to LSP1 in NP-40-soluble lysates 
consists of small F-actin oligomers. Fluorescence measure- 
merits reveal that LSP1 does not influence the kinetics of ac- 
tin polymerization, indicating that it is unlikely that LSP1 
binds to NP-40-soluble actin oligomers serving as nuclei for 
actin polymerization (22).  Therefore, actin bound to LSP1 
in NP-40  lysates most probably represents short actin fila- 
ments released during the lysis of cells in NP-40. 
EM showed that LSP1 bound to the sides of actin filaments 
is able to promote bundling of  these filaments. Whether bun- 
dling is an artifact of the apparent incorporation of rLSP1 
into micelles or is of physiological relevance is unknown. 
Nonmuscle caldesmon bundling of actin filaments has been 
correlated with the self-association of caldesmon through 
disulfide  bonds  (47).  Although  rLSP1  is  not  disulfide 
bonded, it appeared as large 10-20-nm particles in the elec- 
tron microscope,  each possibly containing several rLSPI 
molecules  and  some  detergent.  The  presence  of several 
actin-binding LSP1 molecules in these particles would be ex- 
pected to promote cross-linking of the actin filaments to 
form bundles. 
It has become apparent that the lymphocyte cytoskeleton 
plays an important role in lymphocyte  activation. Two series 
of experiments with sets of monoclonal anti-IgM or anti-IgD 
antibodies showed a strict correlation between the capacity 
of  the antibodies to induce capping and their ability to induce 
the attachment of mlg to the cytoskeleton or to induce a 
mitogenic response in B-lymphocytes (1,  14).  In addition 
Melamed et al. (29) showed that blocking the anti-Ig induced 
F-actin assembly by treatment with cytochalasin D or botuli- 
num C2  toxin prevented subsequent DNA  synthesis. The 
block in DNA synthesis appeared to be distal to activation 
of protein kinase c since treatment with botulinum C2 also 
blocked phorbol ester-induced F-actin assembly and DNA 
synthesis. These results imply a role for the cytoskeleton in 
the early and late stages of the transduction of anti-Ig gener- 
ated signals. LSP1 could be involved in several aspects of  this 
signal transduction process, for instance in the cytoskeleton- 
mediated capping of surface antigen receptors  on B- and 
T-lymphocytes or in the anti-Ig-induced association of mlg 
molecules with the cytoskeleton. The molecular nature of 
the linkage between mlg and the cytoskeleton is unclear. It 
has been postulated that mIg binds directly to actin (11), or 
that specific proteins such as Gc globulin (35) or ot-actinin 
(15) are involved.  However,  it is possible that LSP1 plays a 
role in this process, possibly by binding directly to mlg or 
to  the  recently described  Ig-associated proteins  (7,  16). 
Other roles for LSP1  can, however,  not be excluded. The 
cytoskeleton  participates in the proper functioning of  the im- 
mune system through its involvement in important processes 
such as adhesion of lymphocytes to the specialized high en- 
dothelial venules (HEV) which is the first step in the extrava- 
sation process by which lymphocytes leave the blood stream 
to enter secondary lymphoid organs such as lymph nodes 
(46). The cytoskeleton  must also play a role in regulating the 
dramatic shape changes which lymphocytes must undergo 
when passing between endothelial ceils (2). Furthermore, it 
has been shown that the cytoskeleton  plays a role in the inter- 
actions between helper T-cells and antigen presenting B-cells 
(23, 24) or between cytotoxic T-cells and their targets (13, 
33).  Since LSP1 is present at the strategic interface of the 
plasma membrane with the cell cytoplasm, possibly as part 
of the membrane skeleton, this localization may allow LSP1 
to transmit signals from the lymphocyte membrane to the 
cytoskeleton mediating any of the cytoskeleton-driven re- 
sponses discussed above. 
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